Trial Profile
An open label, retrospective, monocentric, observational study to evaluate Lacosamide retention rates in patients with epilepsy and intellectual disabilities
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy; Mental retardation
- Focus Adverse reactions; Therapeutic Use
- 24 Aug 2017 New trial record
- 14 Aug 2017 Results published in the Epilepsia